In yesterdays interview LC said that over the past years Her-Vaxx formulation has been improved. Not a surprise but looking a bit into the future that opens the door for the option to sell Her-Vaxx IP if the price is right as they have already the next generation of B-cell vax worked out. The PH system, sell the old to finance the next could be applied here again. Deals are worked out at the present, they hinted that to us many times, a deal news could strike at any time as well.
GLTA
Ann: Imugene First Patient Dosed in PD1-VAXX Clinical Trial, page-41
-
- There are more pages in this discussion • 84 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
0.005(9.26%) |
Mkt cap ! $433.6M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.9¢ | 5.4¢ | $1.489M | 25.99M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 35252 | 5.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 1753430 | 24 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |